Reviews the traditional and current prostate-specific imaging techniques for early detection with special emphasis on androgen receptor based imaging.

‘Development of androgen receptor based imaging using nonsteroidal antiandrogen agent is the future direction for early diagnosis of prostate cancer, says study.’

Here, the prostate biology is rethought for nuclear imaging as future modality for early, rapid and efficient diagnosis of prostate cancer. Future direction in prostate cancer imaging involves the development of androgen receptor based imaging using nonsteroidal antiandrogen agent for early diagnosis of prostate cancer. 




Source-Eurekalert